ArticleJournal of cancer research and clinical oncology2025
FSS-ULivR: a clinically-inspired few-shot segmentation framework for liver imaging using unified representations and attention mechanisms.
Article in Journal of cancer research and clinical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- CT-Based Liver Segmentation for Liver Surgery: A Hybrid Approach Based on 3D U-Net-ELM Model.Biomedicines · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Precise liver segmentation is critical for accurate diagnosis and effective treatment planning, serving as a foundation for medical image analysis. However, existing methods struggle with limited labeled data, poor generalizability, and insufficient integration of anatomical and clinical features. To address these limitations, we propose a novel Few-Shot Segmentation model with Unified Liver Representation (FSS-ULivR), which employs a ResNet-based encoder enhanced with Squeeze-and-Excitation modules to improve feature learning, an enhanced prototype module that utilizes a transformer block and channel attention for dynamic feature refinement, and a decoder with improved attention gates and residual refinement strategies to recover spatial details from encoder skip connections. Through extensive experiments, our FSS-ULivR model achieved an outstanding Dice coefficient of 98.94%, Intersection over Union (IoU) of 97.44% and a specificity of 93.78% on the Liver Tumor Segmentation Challenge dataset. Cross-dataset evaluations further demonstrated its generalizability, with Dice scores of 95.43%, 92.98%, 90.72%, and 94.05% on 3DIRCADB01, Colorectal Liver Metastases, Computed Tomography Organs (CT-ORG), and Medical Segmentation Decathlon Task 3: Liver datasets, respectively. In multi-organ segmentation on CT-ORG, it delivered Dice scores ranging from 85.93% to 94.26% across bladder, bones, kidneys, and lungs. For brain tumor segmentation on BraTS 2019 and 2020 datasets, average Dice scores were 90.64% and 89.36% across whole tumor, tumor core, and enhancing tumor regions. These results emphasize the clinical importance of our model by demonstrating its ability to deliver precise and reliable segmentation through artificial intelligence techniques and engineering solutions, even in scenarios with scarce annotated data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.